To date, mutations in microtubule-associated protein tau (MAPT), progranulin (GRN) and chromosome 9 open reading frame 72 (C9orf72) account for the majority of genetically determined FTD (about 30%) [19]. This evidence concerns the gene MAPT and frontotemporal dementia.